Anavex Life Sciences Corp (AVXL)

[sokol]

I fully agree. If anyone watched the Davos panel that included the new head of the FDA, Anavex did precisely what that panel discussed about more efficient clinical trials and faster approval. Anavex improved its chances or odds for approval of its drug. Here is my key quote that is aligned with what was discussed at Davos: 'We are expecting to leverage these important findings to more precisely target patients based on specific genomic profiles that may be highly responsive to ANAVEX®2-73,” said Christopher U Missling, PhD, President and Chief Executive Officer of Anavex. “This should allow us to improve upon existing trial designs and expedite other aspects of our clinical development program.” '